Down 25.8% in 4 Weeks, Here's Why You Should You Buy the Dip in Benitec Biopharma (BNTC) [Yahoo! Finance]
Benitec Biopharma (NASDAQ:BNTC) was given a new $32.00 price target on by analysts at HC Wainwright. They now have a "buy" rating on the stock.
Benitec Biopharma (NASDAQ:BNTC) was upgraded by analysts at Zacks Research from a "strong sell" rating to a "hold" rating.
Citizens Lifts Benitec Biopharma Inc. (BNTC) Price Target on Topline Results for Oculopharyngeal Muscular Dystrophy Treatment [Yahoo! Finance]
Hedge funds investors have a lot riding on Benitec Biopharma Inc. (NASDAQ:BNTC) with 37% ownership [Yahoo! Finance]